Skip to content

Postoperative Course Following Wisdom Tooth Surgery

Postoperative Course and Quality of Life Following Surgical Removal of the Mandibular 3. Molar

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00921479
Enrollment
300
Registered
2009-06-16
Start date
2005-06-30
Completion date
2024-12-31
Last updated
2021-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

third molar, quality of life, postoperative swelling, postoperative pain, Surgical Procedures, Operative, Postoperative Period

Brief summary

The purpose of this study is to determine how quality of life changes after surgical removal of wisdom teeth

Detailed description

A significant percentage of patients are subjected to surgical removal of 3. molars every year. The surgical mucosal and osseous procedure may lead to postoperative discomfort including pain, for the patient. Information with respect to how patients regard the impact of this surgical treatment on oral health including pain and swelling is of great interest. More precise information about the postoperative course following this surgery will be beneficial in improving clinical treatment procedures with respect to alleviating the patients' postoperative period.

Interventions

None listed

Sponsors

University of Oslo
CollaboratorOTHER
Ullevaal University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients of either sex of Caucasian origin, between the age of 18 and 45, who are candidates for surgical removal of one mandibular 3. molar

Exclusion criteria

* Chronic drug treatment (except birth control medication) with analgesics, anti-inflammatory treatment (both steroidal (SAIDs) and non-steroidal anti-inflammatory drugs (NSAIDs)) apart from standard postoperative analgesic treatment administered by the operator. * The necessity for anti-microbial drugs. * Pregnant or lactating women. * Patients with diabetes. * Patients who due to age or communication skills are considered unable to complete patient forms. * Professional evaluation suggests an alteration of the planned surgical area or treatment form. * Surgery exceeding 45 minutes, from time of first incision to completed suturing. * Known or assumed intolerance or hypersensibility to ibuprofen (standard postoperative analgesic treatment). * Known or assumed intolerance or hypersensibility to the standard local anaesthetic Xylocain-adrenalin (lidocaine-adrenalin). * Consumption of alcohol in the period from 2 days before or until the end of the primary observation period (postoperative days 0-7.

Design outcomes

Primary

MeasureTime frameDescription
Oral Health Impact Profile (OHIP-14)7 daysMeasure functional status of the oral cavity

Secondary

MeasureTime frameDescription
Pain Intensity (0-10 Numerical Rating Scale)7 daysSubjective measure pain intensity
Norwegian McGill Pain Questionnaire (NMPQ)7 daysMeasure quantitative and qualitative pain characteristics
Norwegian Translated Short-Form McGill Pain Questionnaire (NTSF-MPQ)7 daysMeasure qualitative and quantitative pain characetristics
Subjective Swelling Assessment (0-10 Numerical rating Scale)7 DaysSubjective assessment of postoperative swelling
Corahs Dental Anxiety Scale (CDAS)1 dayAssessment of preoperative anxiety

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026